Cargando…
Quantifying the therapeutic requirements and potential for combination therapy to prevent bacterial coinfection during influenza
Secondary bacterial infections (SBIs) exacerbate influenza-associated disease and mortality. Antimicrobial agents can reduce the severity of SBIs, but many have limited efficacy or cause adverse effects. Thus, new treatment strategies are needed. Kinetic models describing the infection process can h...
Autor principal: | Smith, Amber M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5376398/ https://www.ncbi.nlm.nih.gov/pubmed/27679506 http://dx.doi.org/10.1007/s10928-016-9494-9 |
Ejemplares similares
-
Bacterial factors required for Streptococcus pneumoniae coinfection with influenza A virus
por: Chen, Yi-Yin, et al.
Publicado: (2021) -
Dynamic Pneumococcal Genetic Adaptations Support Bacterial Growth and Inflammation during Coinfection with Influenza
por: Smith, Amanda P., et al.
Publicado: (2021) -
Host‐pathogen kinetics during influenza infection and coinfection: insights from predictive modeling
por: Smith, Amber M
Publicado: (2018) -
Bacterial Coinfection in COVID-19 and Influenza Pneumonia
por: Musher, Daniel M.
Publicado: (2021) -
Influenza and Bacterial Pathogen Coinfections in the 20th Century
por: Wang, Xuan-Yi, et al.
Publicado: (2011)